logo
Select company
Select metric
-53.62%EBITDA Margin
VS
Market
15
Sector
43
Industry
38
History
50
$ 2.3Close
$ 2.18 - $ 8.93 52-Week Range
Ticker Information

Ticker

VERO

Company Name

VENUS CONCEPT INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

VENUS CONCEPT INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VERO - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -32.23M-53.62%$ 60.11M
3/31/2025$ -39.22M-64.3%$ 61M
12/31/2024$ -36.83M-56.81%$ 64.83M
9/30/2024$ -38.16M-56.79%$ 67.2M
6/30/2024$ -38.26M-54.81%$ 69.81M
3/31/2024$ -26.52M-36.18%$ 73.3M
12/31/2023$ -26.31M-34.46%$ 76.35M
9/30/2023$ -26.5M-32.12%$ 82.51M
6/30/2023$ -32.19M-37.25%$ 86.43M
3/31/2023$ -35.98M-38.43%$ 93.62M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VENUS CONCEPT INC's latest trailing twelve months (TTM) EBITDA % stands at -45.76%.
  • Over the past 5 years, VENUS CONCEPT INC's average EBITDA % has been -39.48%.
  • The median EBITDA % for VENUS CONCEPT INC during this period was -36.04%
  • VENUS CONCEPT INC reached its highest EBITDA % over the past 5 years at -12.94%.
  • The lowest EBITDA % recorded by VENUS CONCEPT INC in the same timeframe -90.93%

VENUS CONCEPT INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
NUWE : NUWELLIS INC -46.12%NAOV : NANOVIBRONIX INC -184.91%MOVE : MOVANO INC -4239.36%BBLG : BONE BIOLOGICS CORP -VTAK : CATHETER PRECISION INC -2519.17%SSKN : STRATA SKIN SCIENCES INC -13.51%TIVC : TIVIC HEALTH SYSTEMS INC -1312.77%AMIX : AUTONOMIX MEDICAL INC -AEMD : AETHLON MEDICAL INC -JAGX : JAGUAR HEALTH INC -327.66%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for VENUS CONCEPT INC is calculated as follows: EBITDA [ $ -69.07M ] / Revenues [ $ 150.96M ]
(=) EBITDA % [ -45.76% ]

VERO - EBITDA Margin, Last 5 years

-90.93%

Minimum

Dec 31, 2020

-12.94%

Maximum

Mar 31, 2022

-39.48%

Average

-36.04%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%